ListarArtículos (Medicina) por materia "Vedolizumab"
Mostrando ítems 1-1 de 1
-
Artículo
Vedolizumab response in inflammatory bowel disease. Two years of follow-up
(Aran Ediciones S.A., 2020)Background: vedolizumab is an α4β7 integrin antagonist. The aim of this study was to evaluate the clinical response and ...